Managing toxicity costs higher for treatment with less-specific targeted agents and chemotherapies.
Higher obesity-driven risk identified for kidney, pancreatic, esophageal, endometrial cancers.
Afatinib caused uterine serous carcinoma tumors to shrink.
Baseline angiopoietin-2 may be able to be used as a predictive factor for lenvatinib response in endocrine cancer.
HER2-positive breast cancer treated with pertuzumab, trastuzumab, and chemotherapy, lived about 16 months longer.
Trastuzumab in combination with standard chemotherapy for breast cancer leads to better outcomes.
Cediranib with carboplatin and paclitaxel improved tumor shrinkage in patients with recurrent cervical cancer.
A biomarker in the blood that may indicate early development of pancreatic cancer
Findings based on large retrospective study of patients with type 2 diabetes.
Researchers have successfully rendered Bacillus anthracis bacteria nontoxic to deliver antibody mimics to cancer cells.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|